tiprankstipranks
Trending News
More News >
Nls Pharmaceutics Ltd (NLSP)
:NLSP
US Market

NLS Pharmaceutics (NLSP) Income Statement

Compare
306 Followers

NLS Pharmaceutics Income Statement

Last quarter (Q2 2025), NLS Pharmaceutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, NLS Pharmaceutics's net income was $-2.22M. See NLS Pharmaceutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.32K$ -11.41K$ -11.41K$ -10.05K$ 0.00
Operating Expenses
$ 4.38M$ 11.81M$ 15.47M$ 11.85M$ 2.30M
Depreciation and Amortization
$ 3.32K$ 11.41K$ 11.41K$ 10.05K$ 0.00
EBITDA
$ -3.63M$ -11.80M$ -15.47M$ -11.85M$ -2.63M
Operating Income
$ -4.38M$ -11.81M$ -15.48M$ -11.86M$ -2.30M
Other Income/Expenses
$ 2.40M$ -364.97K$ -1.01M$ -85.46K$ -562.07K
Pretax Income
$ -1.98M$ -12.17M$ -16.50M$ -11.95M$ -2.86M
Net Income
$ -1.98M$ -12.17M$ -16.50M$ -11.95M$ -2.86M
Per Share Metrics
Basic EPS
$ -26.30$ -3.20$ -8.40$ -8.10$ -5.90
Diluted EPS
$ -26.30$ -3.20$ -8.40$ -8.10$ -5.90
Weighted Average Shares Outstanding
75.30K 3.82M 1.97M 1.47M 481.93K
Weighted Average Shares Outstanding (Diluted)
154.33K 3.82M 1.97M 1.47M 481.93K
Currency in USD

NLS Pharmaceutics Earnings and Revenue History